FDA Adverse Event Malfunction Summary report: N

PUMP, INFUSION, ELASTOMERIC

MDR report key: 3171758 · Received June 17, 2013

Report

Report Number
1416980-2013-15484
Event Type
Malfunction
Date Received
June 17, 2013
Report Date
May 22, 2013
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL INFORMATION: THE CUSTOMER CLARIFIED THAT THE ISSUE WAS A BURST OF THE RESERVOIR. ADDITIONAL INFORMATION: A BATCH REVIEW WAS CONDUCTED AND REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION. EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE FOR EVALUATION. VISUAL EXAMINATION OF THE UNIT DETERMINED THAT THE RESERVOIR RUPTURED IN A FOOTED POSITION. THE RESERVOIR WAS ALSO MICROSCOPICALLY EXAMINED FOR ANY ABNORMALITIES THAT MAY HAVE POTENTIALLY CONTRIBUTED TO THE RUPTURE. NO ABNORMALITIES WERE DETECTED NEAR THE RUPTURE LINE. THE CAUSE OF THIS CONDITION COULD NOT BE DETERMINED. NO OTHER OBSERVATIONS WERE NOTED ON THE UNIT.

Additional Manufacturer Narrative · 1

(B)(4).SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THE TUBING OF A LARGE VOLUME FOLFUSOR HAD DISCONNECTED. THIS OCCURRED AFTER THE DEVICE HAD BEEN CONNECTED TO A PATIENT. THE FOLFUSOR WAS FILLED WITH YONDELIS (TRABECTEDIN). FOLLOWING THE DISCONNECTION, THE FOLFUSOR COULD NOT BE USED AND THE DRUG COULD NOT BE INFUSED. THERE WAS NO ADVERSE EVENT ASSOCIATED WITH THIS ISSUE. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
273925 PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 13A006

Patients

Seq Age Sex Outcome Treatment
1 YONDELIS (TRABECTEDIN)